UNLABELLED: Polyaromatic hydrocarbons, including benzo[a]pyrene (BP), are major tobacco carcinogens. Their carcinogenic effects require metabolic activation by cytochrome p450 (CYP) enzymes. Relative CYP isoform expression is related to tissue-specific tobacco-related squamous cell carcinoma (SCC) susceptibility. There have been conflicting reports regarding relative CYP1A1 and CYP1B1 oral expression, and information regarding CYP1B1 expression in oral tissues is limited. To quantify BP- and tobacco-induced CYP1A1 and CYP1B1 expression in oral SCC cells and oral mucosa. STUDY DESIGN: Real-time qPCR was performed to measure (1) BP-induced CYP1A1 and CYP1B1 mRNA expression in seven oral/other head and neck SCC cell lines (2) CYP1A1 and CYP1B1 mRNA expression in gingiva from 22 smokers and 24 nonsmokers. SCC lines exhibited either similar induction of both isoforms or preferential CYP1A1 induction (CYP1A1-to-CYP1B1 ratios 0.8-4.3). In contrast, gingival tissues from smokers exhibited preferential CYP1B1 induction. Marked interindividual variation in CYP1A1 and CYP1B1 expression was observed among smokers. In vitro conditions may not account for factors that modulate expression in vivo. Interindividual variation in inducible CYP1A1 and CYP1B1 expression may account in part for variation in tobacco-related oral SCC risk.
UNLABELLED: Polyaromatic hydrocarbons, including benzo[a]pyrene (BP), are major tobaccocarcinogens. Their carcinogenic effects require metabolic activation by cytochrome p450 (CYP) enzymes. Relative CYP isoform expression is related to tissue-specific tobacco-related squamous cell carcinoma (SCC) susceptibility. There have been conflicting reports regarding relative CYP1A1 and CYP1B1 oral expression, and information regarding CYP1B1 expression in oral tissues is limited. To quantify BP- and tobacco-induced CYP1A1 and CYP1B1 expression in oral SCC cells and oral mucosa. STUDY DESIGN: Real-time qPCR was performed to measure (1) BP-induced CYP1A1 and CYP1B1 mRNA expression in seven oral/other head and neck SCC cell lines (2) CYP1A1 and CYP1B1 mRNA expression in gingiva from 22 smokers and 24 nonsmokers. SCC lines exhibited either similar induction of both isoforms or preferential CYP1A1 induction (CYP1A1-to-CYP1B1 ratios 0.8-4.3). In contrast, gingival tissues from smokers exhibited preferential CYP1B1 induction. Marked interindividual variation in CYP1A1 and CYP1B1 expression was observed among smokers. In vitro conditions may not account for factors that modulate expression in vivo. Interindividual variation in inducible CYP1A1 and CYP1B1 expression may account in part for variation in tobacco-related oral SCC risk.
Authors: Shigeyuki Uno; Timothy P Dalton; Nadine Dragin; Christine P Curran; Sandrine Derkenne; Marian L Miller; Howard G Shertzer; Frank J Gonzalez; Daniel W Nebert Journal: Mol Pharmacol Date: 2005-12-23 Impact factor: 4.436
Authors: Gilka Jorge Figaro Gattás; Marcos Brasilino de Carvalho; Maria Salete Siraque; Otávio A Curioni; Priscila Kohler; Jose Eluf-Neto; Victor Wünsch-Filho Journal: Head Neck Date: 2006-09 Impact factor: 3.147
Authors: Nagathihalli S Nagaraj; Simone Beckers; John K Mensah; Sabine Waigel; Nadarajah Vigneswaran; Wolfgang Zacharias Journal: Toxicol Lett Date: 2006-04-18 Impact factor: 4.372
Authors: Todd J Page; Scott O'Brien; Karrie Holston; Peter S MacWilliams; Colin R Jefcoate; Charles J Czuprynski Journal: Toxicol Sci Date: 2003-05-02 Impact factor: 4.849
Authors: Arvind P Singh; Parag P Shah; Neeraj Mathur; Jeroen T M Buters; Mohan C Pant; Devendra Parmar Journal: Mutat Res Date: 2007-11-05 Impact factor: 2.433
Authors: Lenka Umannová; Miroslav Machala; Jan Topinka; Zuzana Nováková; Alena Milcová; Alois Kozubík; Jan Vondrácek Journal: Mutat Res Date: 2008-02-09 Impact factor: 2.433
Authors: Ekaterina G Shatalova; Andres J P Klein-Szanto; Karthik Devarajan; Edna Cukierman; Margie L Clapper Journal: Cancer Prev Res (Phila) Date: 2012-12-31
Authors: Anna G Zygogianni; George Kyrgias; Petros Karakitsos; Amanta Psyrri; John Kouvaris; Nikolaos Kelekis; Vassilis Kouloulias Journal: Head Neck Oncol Date: 2011-01-06
Authors: Bruno Almeida Lopes; Mariana Emerenciano; Bruno Alves Aguiar Gonçalves; Tállita Meciany Vieira; Ana Rossini; Maria S Pombo-de-Oliveira Journal: PLoS One Date: 2015-05-18 Impact factor: 3.240
Authors: Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner Journal: Pharmaceuticals (Basel) Date: 2021-05-27